TABLE 3. Five-year relative survival for men with prostate cancer, by period and selected characteristics — United States, 2001–2016*.
| Characteristic | 2001–2016 |
2001–2005 |
2006–2010 |
2011–2016 |
||||
|---|---|---|---|---|---|---|---|---|
| No. | Relative survival % (95% CI) | No. | Relative survival % (95% CI) | No. | Relative survival % (95% CI) | No. | Relative survival % (95% CI) | |
|
Overall
|
3,104,380
|
97.6 (97.5–97.6)
|
965,748
|
97.3 (97.2–97.4)
|
1,052,255
|
98.2 (98.1–98.3)
|
1,086,532
|
97.2 (97.1–97.3)
|
|
Age group (yrs)
| ||||||||
| ≤49 |
83,692 |
96.7 (96.6–96.9) |
25,688 |
96.3 (96.0–96.6) |
31,384 |
97.1 (96.8–97.3) |
26,621 |
96.9 (96.5–97.2) |
| 50–54 |
214,757 |
97.8 (97.6–97.9) |
63,318 |
97.8 (97.6–98.0) |
76,549 |
97.9 (97.7–98.1) |
74,893 |
97.4 (97.2–97.7) |
| 55–59 |
407,302 |
98.4 (98.3–98.5) |
117,213 |
98.6 (98.4–98.7) |
143,170 |
98.6 (98.5–98.7) |
146,920 |
97.7 (97.5–97.9) |
| 60–64 |
559,872 |
98.8 (98.8–98.9) |
154,088 |
98.7 (98.6–98.9) |
195,058 |
99.2 (99.1–99.4) |
210,727 |
98.4 (98.2–98.6) |
| 65–69 |
650,004 |
99.6 (99.5–99.7) |
185,518 |
99.1 (98.9–99.3) |
213,975 |
99.9 (99.7–100.0) |
250,514 |
99.5 (99.3–99.6) |
| 70–74 |
525,876 |
99.5 (99.4–99.6) |
175,220 |
99.1 (98.8–99.3) |
171,457 |
99.9 (99.9–100.0) |
179,201 |
99.3 (99.0–99.4) |
| 75–79 |
361,735 |
98.4 (98.2–98.6) |
134,039 |
98.0 (97.6–98.3) |
120,166 |
99.0 (98.7–99.2) |
107,532 |
97.7 (97.4–98.0) |
| ≥80 |
301,315 |
84.6 (84.2–84.9) |
110,671 |
85.7 (85.2–86.3) |
100,506 |
86.9 (86.3–87.4) |
90,144 |
79.7 (78.9–80.6) |
|
Race/Ethnicity†
| ||||||||
| White |
2,323,828 |
97.9 (97.9–98.0) |
752,786 |
97.8 (97.7–97.9) |
792,482 |
98.6 (98.5–98.6) |
778,682 |
97.3 (97.2–97.5) |
| Black |
459,665 |
95.6 (95.4–95.7) |
130,818 |
94.8 (94.6–95.1) |
152,416 |
96.1 (95.9–96.3) |
176,445 |
95.7 (95.3–95.9) |
| AI/AN |
11,983 |
95.7 (94.7–96.6) |
3,361 |
94.6 (92.7–96.1) |
3,991 |
96.4 (94.8–97.5) |
4,632 |
95.5 (93.2–97.1) |
| API |
55,310 |
95.1 (94.8–95.5) |
14,865 |
95.4 (94.7–96.0) |
18,207 |
95.5 (94.9–96.0) |
22,241 |
94.7 (93.9–95.3) |
| Hispanic |
193,770 |
95.3 (95.1–95.5) |
52,951 |
94.9 (94.5–95.2) |
64,680 |
96.0 (95.7–96.3) |
76,154 |
95.2 (94.8–95.6) |
|
Stage*
| ||||||||
| Localized |
2,393,365 |
100.0§ |
753,909 |
100.0§ |
836,008 |
100.0§ |
803,466 |
100.0§ |
| Regional |
328,421 |
98.6 (98.5–98.7) |
87,320 |
97.5 (97.3–97.8) |
106,635 |
99.0 (98.8–99.2) |
134,467 |
99.3 (98.9–99.5)¶ |
| Distant |
145,923 |
30.7 (30.4–31.0) |
37,195 |
28.7 (28.1–29.2) |
40,895 |
30.2 (29.7–30.8) |
67,835 |
32.3 (31.6–33.0)¶ |
| Unknown |
236,919 |
84.3 (84.0–84.5) |
87,357 |
83.0 (82.6–83.4) |
68,748 |
84.2 (83.7–84.6) |
80,818 |
86.7 (86.1–87.2)¶ |
|
Stage by race/ethnicity
| ||||||||
|
Localized
| ||||||||
| White |
1,807,824 |
100.0§ |
592,631 |
100.0§ |
634,465 |
100.0§ |
580,741 |
100.0§ |
| Black |
354,643 |
100.0§ |
99,964 |
100.0§ |
121,260 |
100.0§ |
133,420 |
100.0§ |
| AI/AN |
8,626 |
100.0§ |
2,477 |
99.9 (97.3–100.0) |
2,960 |
100.0§ |
3,189 |
100.0§ |
| API |
41,192 |
99.6 (99.1–99.8) |
11,622 |
99.6 (98.1–99.9) |
13,940 |
99.6 (98.6–99.9) |
15,631 |
99.8 (97.4–100.0) |
| Hispanic |
142,007 |
100.0§ |
39,557 |
100.0§ |
48,798 |
100.0§ |
53,655 |
100.0§ |
|
Regional
| ||||||||
| White |
254,394 |
98.6 (98.5–98.8) |
68,723 |
97.5 (97.2–97.7) |
83,382 |
99.0 (98.7–99.2) |
102,290 |
99.4 (99.0–99.7)¶ |
| Black |
42,843 |
98.8 (98.3–99.1) |
11,027 |
97.9 (96.9–98.5) |
13,494 |
99.3 (98.3–99.7) |
18,322 |
98.9 (97.7–99.5) |
| AI/AN |
1,366 |
98.2 (93.2–99.5) |
354 |
97.3 (87.8–99.4) |
431 |
98.5 (82.2–99.9) |
581 |
97.5 (79.3–99.7) |
| API |
6,671 |
97.4 (96.5–98.1) |
1,491 |
97.1 (95.0–98.4) |
2,091 |
97.9 (96.3–98.9) |
3,089 |
96.9 (94.7–98.2) |
| Hispanic |
20,794 |
97.5 (97.0–98.0) |
5,145 |
96.8 (95.7–97.7) |
6,424 |
97.9 (96.9–98.5) |
9,225 |
98.0 (96.7–98.8) |
|
Distant
| ||||||||
| White |
101,621 |
29.1 (28.7–29.5) |
25,864 |
27.2 (26.6–27.9) |
28,392 |
28.5 (27.9–29.1) |
47,367 |
30.8 (29.9–31.6)¶ |
| Black |
28,330 |
31.6 (30.9–32.3) |
7,718 |
29.9 (28.6–31.1) |
8,047 |
31.0 (29.9–32.2) |
12,565 |
33.3 (31.8–34.9)¶ |
| AI/AN |
796 |
32.2 (27.8–36.8) |
180 |
29.0 (21.6–36.8) |
219 |
27.9 (21.3–34.8) |
397 |
39.0 (30.4–47.4) |
| API |
3,153 |
42.0 (39.6–44.3) |
650 |
38.1 (33.9–42.3) |
853 |
43.3 (39.5–47.0) |
1,650 |
41.5 (36.8–46.1) |
| Hispanic |
11,418 |
37.2 (36.1–38.4) |
2,655 |
35.3 (33.3–37.4) |
3,213 |
37.4 (35.5–39.3) |
5,550 |
37.5 (35.2–39.9) |
|
Unknown
| ||||||||
| White |
160,180 |
82.8 (82.5–83.2) |
65,593 |
83.3 (82.8–83.8) |
46,266 |
82.0 (81.4–82.5) |
48,322 |
83.0 (82.2–83.8) |
| Black |
33,879 |
79.1 (78.3–79.8) |
12,113 |
78.3 (77.1–79.5) |
9,619 |
78.8 (77.5–80.0) |
12,148 |
80.9 (79.3–82.4) |
| AI/AN |
1,196 |
82.2 (78.1–85.7) |
350 |
76.9 (69.4–82.8) |
381 |
84.6 (77.6–89.6) |
465 |
84.1 (74.8–90.3) |
| API |
4,298 |
82.7 (80.9–84.4) |
1,102 |
82.0 (78.5–84.9) |
1,323 |
81.1 (78.0–83.7) |
1,873 |
85.4 (81.5–88.5) |
| Hispanic | 19,572 | 84.4 (83.5–85.2) | 5,598 | 80.6 (79.0–82.1) | 6,249 | 86.5 (85.1–87.7) | 7,727 | 85.8 (83.9–87.6)¶ |
Source: CDC’s National Program of Cancer Registries. https://www.cdc.gov/cancer/npcr.
Abbreviations: AI/AN = American Indian/Alaska Native; API = Asian/Pacific Islander; CI = confidence interval.
* Data were compiled from 45 population-based registries that cover approximately 94% of the U.S. population. Counts for age and stage do not sum to the total because of multiple primaries methodology. When the relative survival is calculated stratified by a tumor or demographic characteristic, each cancer was included for patients diagnosed with multiple primary prostate cancers at the different category levels.
†White, Black, AI/AN, and API men are non-Hispanic. Hispanic men might be of any race. Counts exclude unspecified or unknown race/ethnicity. Excludes 59,824 cases of non-Hispanic unknown race.
§ CI could not be calculated.
¶ Indicates nonoverlapping 95% CIs when comparing 2001–2005 with 2011–2016.